RO5166017
跳转到导航
跳转到搜索
| File:RO5166017 structure.png | |
| 临床资料 | |
|---|---|
| 药物类别 | Trace amine-associated receptor 1 (TAAR1) partial or near-full agonist |
| 识别信息 | |
| |
| CAS号 | 1048346-74-2 |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| E编码 | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Module:EditAtWikidata第29行Lua错误:attempt to index field 'wikibase' (a nil value) |
| 化学信息 | |
| 化学式 | C12H17N3O |
| 摩尔质量 | 219.29 g·mol−1 |
| 3D模型(JSmol) | |
| |
| |
RO5166017或RO-5166017是一种含氮有机化合物,化学式C
12H
17N
3O,属于一种痕量胺相关受体TAAR1的选择性激动剂[1],由罗氏制药研发[2]。
参考文献[编辑]
- ^ Revel FG, Moreau JL, Pouzet B, Mory R, Bradaia A, Buchy D, Metzler V, Chaboz S, Groebke Zbinden K, Galley G, Norcross RD, Tuerck D, Bruns A, Morairty SR, Kilduff TS, Wallace TL, Risterucci C, Wettstein JG, Hoener MC. A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight. Mol Psychiatry. May 2013, 18 (5): 543–556. PMID 22641180. doi:10.1038/mp.2012.57.
- ^ Revel FG, Moreau JL, Gainetdinov RR, Bradaia A, Sotnikova TD, Mory R, Durkin S, Zbinden KG, Norcross R, Meyer CA, Metzler V, Chaboz S, Ozmen L, Trube G, Pouzet B, Bettler B, Caron MG, Wettstein JG, Hoener MC. TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc Natl Acad Sci U S A. May 2011, 108 (20): 8485–8490. Bibcode:2011PNAS..108.8485R. PMC 3101002 可免费查阅. PMID 21525407. doi:10.1073/pnas.1103029108 可免费查阅.